Next-Generation Marrow Stimulation Technology for Cartilage Repair: Basic Science to Clinical Application.

Area of Science:

• Orthopedics and Sports Medicine
• Regenerative Medicine
• Biomaterials Science

Background:

• Articular cartilage lesions are prevalent, even in younger patients (<40 years), and sometimes only detected during arthroscopy.
• First-generation marrow stimulation (MS), like microfracture, shows diminishing returns after 24 months but remains beneficial for specific lesion sizes (2-3 cm²).
• Autologous chondrocyte implantation (ACI) and osteochondral allograft (OCA) transplantation are viable for failed MS cases.

Purpose of the Study:

• To review key principles for cartilage defect preparation.
• To highlight recent advancements in marrow stimulation (MS) techniques.
• To identify scaffolding augmentation strategies for enhanced cartilage regeneration.

Main Methods:

• Review of basic science principles influencing MS techniques.
• Analysis of recent clinical studies on next-generation cartilage repair applications.
• Evaluation of scaffolding augmentation strategies, including Mesenchymal Augmentation and Scaffold Stimulation (MASS).

Main Results:

• Improved defect preparation techniques include creating vertical walls, increasing subchondral penetration depth, using smaller awl diameters, and increasing perforations.
• Next-generation applications involve scaffolds like hyaluronic acid-based, atelocollagen-based gel, micronized allogeneic cartilage, and PEG-diacrylate/denatured fibrinogen hydrogels.
• Scaffolding strategies show potential to overcome limitations of traditional MS.

Conclusions:

• Optimized defect preparation and advanced MS techniques are crucial for cartilage regeneration.
• Novel scaffolding materials and strategies offer promising avenues for improving cartilage repair outcomes.
• Further research and clinical trials are essential to validate these next-generation approaches.